Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
304,488
-4,864
-2% -$27.1K 0.09% 195
2026
Q1
$1.21M Sell
309,352
-38,000
-11% -$169K 0.06% 268
2025
Q4
$1.58M Sell
347,352
-29,399
-8% -$151K 0.07% 231
2025
Q3
$2.31M Sell
376,751
-34,072
-8% -$216K 0.1% 181
2025
Q2
$2.66M Hold
410,823
0.13% 163
2025
Q1
$2.18M Buy
410,823
+29,687
+8% +$203K 0.13% 176
2024
Q4
$3.2M Buy
381,136
+341,136
+853% +$2.63M 0.17% 131
2024
Q3
$316K Buy
+40,000
New +$360K 0.02% 502

Other funds holding TBI

RBF Capital's TBI Position: Q2 2026 in Review

RBF Capital reduced its Trueblue (TBI) stake by 1.6% in Q2 2026, selling an estimated $27.1K and leaving 304,488 shares worth $2.12M. The position accounts for 0.09% of the portfolio, ranked #195.

RBF Capital first reported a position in TBI in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.2M in Q4 2024. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • RBF Capital held 304,488 shares of Trueblue worth $2.12M as of Q2 2026.
  • RBF Capital sold 4,864 Trueblue shares in Q2 2026, an estimated $27.1K.
  • Trueblue made up 0.09% of RBF Capital's portfolio in Q2 2026, its #195 holding.
  • RBF Capital first reported a position in Trueblue in Q3 2024 and has held it in 8 quarters since.
  • RBF Capital's Trueblue position peaked at $3.2M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.